Efficacy and safety of abaloparatide, denosumab, teriparatide, oral bisphosphonates, and intravenous bisphosphonates in the treatment of male osteoporosis: a systematic review and Bayesian network meta-analysis
Study DesignA Systematic Review and Bayesian Network Meta-AnalysisObjectiveTo compare the efficacy and safety of abaloparatide (ABA), denosumab (DEN), teriparatide (TER), oral bisphosphonates (OBP), and intravenous bisphosphonates (IBP) in the treatment of male osteoporosis through a network meta-an...
Saved in:
| Main Authors: | Liangshi Chen, Bomei Ji, Cong Xia |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-04-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1558560/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current treatment of osteoporosis
by: Subramanian Nallasivan
Published: (2019-01-01) -
Comparative efficacy of teriparatide and bisphosphonates or denosumab vs. teriparatide monotherapy in osteoporosis: a meta-analysis
by: Huan Jin, et al.
Published: (2025-05-01) -
Combination or sequential teriparatide for osteoporosis treatment in denosumab-users: real-world bone mineral density outcomes
by: Shejil KUMAR, et al.
Published: (2025-06-01) -
Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects
by: Harsh Durgia, et al.
Published: (2025-01-01) -
The efficacy and safety of denosumab, risedronate, alendronate and teriparatide to treat male osteoporosis: a systematic review and bayesian network meta-analysis
by: Shu Jun Chai, et al.
Published: (2025-06-01)